New to Meducation?
Sign up
Already signed up? Log In
view moderators

LungNeoplasms

Category

Preview
0
2

Treating HER2 Lung Cancers: The EUHER2 Cohort

Is trastuzumab beneficial in combination with chemotherapy for advanced HER2-positive advanced NSCLC?  
medscape.com
over 3 years ago
Preview
0
3

Added Value of Quantitative FDG-PET Parameters in NSCLC Prognosis

By incorporating additional PET imaging features related to tumor heterogeneity, researchers are able to better predict survival in patients with lung cancer, according to a new study.  
medscape.com
over 3 years ago
Preview
0
0

FDA OKs Crizotinib (Xalkori) for ROS-1-Mutated Lung Cancer

The FDA has approved crizotinib for the treatment for patients with ROS-1-positive non-small cell lung cancer.  
medscape.com
over 3 years ago
Preview
0
0

Role for Twitter in Cancer Clinical Trial Recruitment?

A pilot study using a sample of tweets about lung cancer found that a surprising amount of these were about clinical trials, suggesting Twitter could be a resource for recruitment.  
medscape.com
over 3 years ago
Preview
2
18

Hoarseness as an anatomical complication of lung cancer

This video is part of a playlist of short videos which are intended to combine multiple choice questions' answering experience with an improved understanding...  
youtube.com
over 3 years ago
Preview
0
0

Low-Dose CT Lung Cancer Screening Programs in the U.S.

What are the biggest challenges to implementing low-dose CT lung cancer screening programs in the United States?  
medscape.com
over 3 years ago
Preview
0
0

Translating Lung Cancer Screening Guidelines Into Practice

New lung cancer screening guidelines, as implemented at one community hospital, resulted in a much higher number of follow-ups than anticipated.  
medscape.com
over 3 years ago
Preview
0
0

My mother's favourite flower: A life remembered - BBC News

Celine Marchbank's personal pictures of her mother who was diagnosed with lung cancer and a brain tumour.  
bbc.co.uk
over 3 years ago
Preview
0
0

The Case for Next-Gen Sequencing in Every Lung Cancer Patient

Dr Mark Kris talks about the recent developments in next-generation molecular sequencing and their value for patients with lung cancer.  
medscape.com
over 3 years ago
Preview
0
0

EU Expands Nivolumab Approval For Lung and Kidney Cancer

Nivolumab is now approved in Europe for both nonsquamous- and squamous-type non-small-cell lung cancer, as well as for use in renal cell carcinoma.  
medscape.com
over 3 years ago
Preview
0
2

European Lung Cancer Conference (ELCC) 2016

European Lung Cancer Conference (ELCC) 2016: Read clinically focused news coverage of key developments from ELCC 2016.  
medscape.com
over 3 years ago
Preview
0
7

A Dose of Reality in Low-Dose CT Lung Cancer Screening

Some controversy remains regarding the adoption of wide-scale LDCT screening for lung cancer.  
medscape.com
over 3 years ago
Preview
0
7

Multidisciplinary Care Takes Center Stage at ELCC 2016

Immunotherapy, oncogene inhibition, and the role of surgery and radiotherapy will be discussed at the European Lung Cancer Conference (ELCC) 2016 in Geneva.  
medscape.com
over 3 years ago
Preview
0
6

FDA Panel Denies Accelerated Approval of Lung Cancer Drug

A rival drug was the elephant in the room at the Oncologic Drugs Advisory Committee meeting, where the panel voted against rociletinib.  
medscape.com
over 3 years ago
Preview
0
7

Lung Cancer Clinicians Urged to Look Beyond RCT Data

Given the difficulties in conducting randomized controlled trials in lung cancer, clinicians should look to observational and registry data to support decision-making, said a leading expert.  
medscape.com
over 3 years ago
Preview
0
6

Lung Cancer Admissions Down, but Hospital Costs Up

Although the number of admissions for lung cancer and in-hospital mortality decreased significantly over the past decade, the cost per hospitalization almost doubled, say US investigators.  
medscape.com
over 3 years ago
Preview
0
7

Are Clinically Diagnosed Lung Cancer Patients Overtreated?

Clinically diagnosed early-stage lung cancer patients have significantly longer cancer-specific survival than pathologically diagnosed patients, suggesting they are overtreated for benign disease.  
medscape.com
over 3 years ago
Preview
0
7

Next-Gen Sequencing Every Lung Cancer: Lessons From France

A large French study has clearly demonstrated the benefit of completely sequencing every lung cancer, says Dr Mark Kris.  
medscape.com
over 3 years ago
Preview
0
8

New Immunotherapies Bring New Questions in Lung Cancer

Dr Mark Kris assesses the complicated risks and benefits of using nivolumab and pembrolizumab for patients with lung cancers.  
medscape.com
over 3 years ago
Preview
0
11

Using Immunohistochemistry to Predict Anti-PD1/PDL1 Activity

Which patients with lung cancer will respond to anti-PD-1/PD-L1 therapies?  
medscape.com
over 3 years ago